Sales 2024 * | 2.75B 2.93B | Sales 2025 * | 2.74B 2.93B | Capitalization | 19.12B 20.44B |
---|---|---|---|---|---|
Net income 2024 * | -419M -448M | Net income 2025 * | -548M -586M | EV / Sales 2024 * | 2.35 x |
Net cash position 2024 * | 12.67B 13.55B | Net cash position 2025 * | 12.02B 12.85B | EV / Sales 2025 * | 2.59 x |
P/E ratio 2024 * |
-43.8
x | P/E ratio 2025 * |
-34.7
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 86.48% |
Latest transcript on BioNTech SE
Managers | Title | Age | Since |
---|---|---|---|
Ugur Sahin
CEO | Chief Executive Officer | 58 | 08-06-01 |
Özlem Türeci
FOU | Founder | 57 | 08-06-01 |
Jens Holstein
DFI | Director of Finance/CFO | 60 | 21-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Rudolf Staudigl
BRD | Director/Board Member | 70 | 21-12-31 |
Director/Board Member | 67 | 08-06-01 | |
Helmut Jeggle
CHM | Chairman | 53 | 08-06-01 |
1st Jan change | Capi. | |
---|---|---|
+15.19% | 121B | |
+19.91% | 114B | |
+8.24% | 23.61B | |
-16.19% | 16.55B | |
-13.45% | 16.45B | |
-44.35% | 15.59B | |
+2.13% | 13.54B | |
+66.67% | 15.19B | |
+119.39% | 10.96B |